Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × encorafenib × Clear all

Phase

Phase 2 2 Phase 4 1 Phase 1 1

Status

Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Metformin 3 Letrozole 3 Sperm Injections, Intracytoplasmic 2 Progesterone 2 Lidocaine 2 Indocyanine Green 2 Gentamicins 2 Estradiol 2 Clomiphene 2 Bevacizumab 2 Acitretin 2 tirbanibulin 1 technetium Tc 99m nanocolloid 1 suvorexant 1 pomalidomide 1 pembrolizumab 1 pasireotide 1 nilotinib 1 methylnaltrexone 1 ledipasvir 1 ixazomib 1 gadolinium ethoxybenzyl DTPA 1 gadofosveset trisodium 1 exemestane 1 encorafenib 1 dolutegravir 1 ceftolozane, tazobactam drug combination 1 binimetinib 1 bicalutamide 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07092410 2026-04-21

SuRage-EB

SRH Wald-Klinikum Gera GmbH

Phase 4 Withdrawn

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡